Nature's Sunshine Products Inc(NATR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 12.35 | EPS (ttm) | 1 | Insider Own | 6.16% | Shs Outstand | 17.6M | Perf Week | -2.52% |
| Market Cap | 0.22B | Forward P/E | 10.07 | EPS next Y | 13.89% | Insider Trans | 13.12% | Shs Float | 16.5M | Perf Month | -3.43% |
| Enterprise Value | 0.16B | PEG | - | EPS next Q | 0.27 | Inst Own | 92.99% | Short Float | 5.56% | Perf Quarter | -39.77% |
| Income | 0.02B | P/S | 0.44 | EPS this Y | -14.29% | Inst Trans | 5.61% | Short Ratio | 5.76 | Perf Half Y | -54.43% |
| Sales | 0.49B | P/B | 1.29 | EPS next 5Y | -1.07% | ROA | 7.03% | Short Interest | 0.92M | Perf YTD | -42.59% |
| Book/sh | 9.61 | P/C | 2.64 | EPS past 3/5Y | - -0.22% | ROE | 11.07% | 52W High | -55.97% ($28.14) | Perf Year | -9.96% |
| Cash/sh | 4.69 | P/FCF | 12.05 | Sales past 3/5Y | 4.4% 4.5% | ROIC | 9.71% | 52W Low | 3.23% ($12.00) | Perf 3Y | -28.42% |
| Dividend Est. | - | EV/EBITDA | 3.68 | EPS Y/Y TTM | 34.53% | Gross Margin | 70.45% | Volatility(W/M) | 2.99% 2.9% | Perf 5Y | -20.27% |
| Dividend TTM | - | EV/Sales | 0.32 | Sales Y/Y TTM | 6.77% | Oper. Margin | 5.96% | ATR (14) | 0.39 | Perf 10Y | -0.13% |
| Dividend Ex-Date | 2021/3/26 | Quick Ratio | 1.55 | EPS Q/Q | -31.4% | Profit Margin | 3.68% | RSI (14) | 38.43 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.6 | Sales Q/Q | 1.95% | SMA20 | -1.11% ($12.53) | Beta | 0.8 | Target Price | $30.5 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2026/11/4 | SMA50 | -6.18% ($13.21) | Rel Volume | 0.5 | Prev Close | $12.27 |
| Employees | 806 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | -22.22% -5.43% | SMA200 | -40.16% ($20.71) | Avg Volume(3M) | 0.16M | Price | $12.39 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 1425 | Volume | 79,176 | Change | 0.98% |
🌿 Established in 1972, it is a global health functional food and personal care manufacturing and distribution company. Headquartered in Utah, USA, it supplies nutritional supplements, herbal products, immunity and weight management products across more than 40 countries through direct sales and a digital subscription economy platform, building a stable health and wellness brand value.
Over the past 1 year, on the lower side
56% below its 1-year high.
Traded less than usual. That is 50% of its average volume.
Next earnings report: November 4
7 days to go.
NATR makes money exceptionally well
Of every $100 in sales, $5.96 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -14.3% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $1,235. Peers typically go for $1,445. Compared with its own 5-year average, it is 39% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -20.3%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 93.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #38 of 61 in the industry
Based on market cap of $218M.
BRCC#36 BRC Inc $290M PER - 
USNA#37 Usana Health Sciences Inc $260M PER - NATR#38 Nature's Sunshine Products Inc $218M PER 12.3 
NAGE#39 Niagen Bioscience Inc $198M PER 13.3 
BGS#40 B&G Foods Inc $169M PER - 
FAQ
What kind of company is NATR?
NATR belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of NATR?
The market cap of NATR is approximately $218M, ranking 3,954 within its sector.
What is the P/E ratio of NATR?
NATR has a P/E ratio of approximately 12.3x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for NATR?
NATR has recorded a 52-week high of $28.14 and a low of $12.00.
